Book a Meeting

Inquiry

CellFace™ Cell-Antibody (Anti-KDR) Conjugation (CAT#: CF-0922-ZP305)

DataSheet

Product Overview
DescriptionEmploying live cells as therapeutics is a direction of future drug discovery. An easy and robust method to modify the surfaces of cells directly to incorporate novel functionalities is highly desirable. However, genetic methods for cell-surface engineering are laborious and limited by low efficiency for primary cell modification. Creative Biolabs has developed a single-step chemoenzymatic CellFace™ technology platform to transfer bio-macromolecules, such as an IgG antibody (MW∼ 150 KD), to the glycocalyx on the surfaces of live cells. Requiring no genetic modification, our CellFace™ allows for any antibody to be conjugated to the stimulatory surface receptors of immune cells to yield the additive effect of superior tumor targeting to its already potent and off-the-shelf biologic drug payloads.

We applied CellFace™ to construct the CellFace™ cell-antibody conjugation (CAC). CellFace™ CAC can be prepared from multiple immune cells and stem cells, such as T cells, NK cells, macrophages, and mesenchymal stem cells. The modified CAC is expected to overcome the challenges that have prevented cell therapies from effectively targeting solid tumors.
Available FormatsCellFace™ T Cell-Antibody (Anti-KDR) Conjugation
CellFace™ NK Cell-Antibody (Anti-KDR) Conjugation
CellFace™ MA Cell-Antibody (Anti-KDR) Conjugation
CellFace™ MSC Cell-Antibody (Anti-KDR) Conjugation
CellFace™ HSC Cell-Antibody (Anti-KDR) Conjugation
Engineered MoleculesAntibody
Cell TypeT Cell; NK Cell; Macrophage; HSC; MSC; TIL; CIK; γδ T Cell; Treg; Dendritic Cell; Fibroblast; Chondrocyte; iPSC; B Cell
Application NotesThe CAC can be customized with both cell lines and primary cells according to customer needs. Please contact us for specific cells you needs.

Target
TargetKDR
Official NameKDR
Full NameKinase Insert Domain Receptor
SynonymsRamucirumab; Cyramza; 947687-13-0; IMC-1121B; LY3009806; IMC-1121B; Cyramza; KDR; kinase insert domain receptor (a type III receptor tyrosine kinase); vascular endothelial growth factor receptor 2; CD309; FLK1; VEGFR; VEGFR2; soluble VEGFR2; fetal liver kinase 1

Quality Control
Research Use OnlyFor research use only, not for diagnostic or therapeutic use.
Related products

All services are only provided for research purposes and Not for clinical use.

ONLINE INQUIRY
  • *
  • *
  • *
USA

United Kingdom

Germany